Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Richard Thomas Meehan"'
Publikováno v:
Diagnostics, Vol 11, Iss 8, p 1362 (2021)
Despite the growing number of biologic and JAK inhibitor therapeutic agents available to treat various systemic autoimmune illnesses, the lack of a validated companion diagnostic (CDx) to accurately predict drug responsiveness for an individual resul
Externí odkaz:
https://doaj.org/article/9cafb13606f247cda62a5820954b0302
Autor:
Chris Wilson, Lynne Altimier, Elizabeth A. Regan, Maryanne Kaessner, Richard Thomas Meehan, Eric A. Hoffman
Publikováno v:
Journal of Orthopaedic Research. 37:601-608
Synovial fluid based biomarker research has been limited by the small volumes of synovial fluid from the knees of some patients. We used ultrasound (US) to determine if synovial fluid could be displaced into an access port during pneumatic compressio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f923fc795102113be811d7188f5cf9fb
https://doi.org/10.1002/jor.24216
https://doi.org/10.1002/jor.24216
Autor:
Vijaya Knight, John C. Hill, Karin A. Pacheco, Richard Thomas Meehan, Richard A Scheuring, Molly L. Wolf, James L. Crooks, Prashant J Parmar, Eric D Hoffman, Mary T Gill, Elizabeth A. Regan
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 5027, p 5027 (2021)
Journal of Clinical Medicine
Volume 10
Issue 21
Journal of Clinical Medicine
Volume 10
Issue 21
Background: There are currently no effective disease-modifying drugs to prevent cartilage loss in osteoarthritis and synovial fluid is a potentially valuable source of biomarkers to understand the pathogenesis of different types of arthritis and iden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61dff20459b276c74372d7942176dfd0
https://doi.org/10.3390/jcm10215027
https://doi.org/10.3390/jcm10215027
Publikováno v:
Diagnostics
Diagnostics, Vol 11, Iss 1362, p 1362 (2021)
Diagnostics, Vol 11, Iss 1362, p 1362 (2021)
Despite the growing number of biologic and JAK inhibitor therapeutic agents available to treat various systemic autoimmune illnesses, the lack of a validated companion diagnostic (CDx) to accurately predict drug responsiveness for an individual resul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02fab8fad7a263c2eaf2d01f997ea51b
https://doi.org/10.3390/diagnostics11081362
https://doi.org/10.3390/diagnostics11081362